Association Between Attention-Deficit/Hyperactivity Disorder and Asthma Among Adults: A Case-Control Study

Affiliations

¹ PharmacoTherapy, -Epidemiology, and -Economics Research Group, Groningen Research Institute of Pharmacy, University of Groningen, Groningen, the Netherlands. Electronic address: j.van.der.schans@rug.nl.
² PharmacoTherapy, -Epidemiology, and -Economics Research Group, Groningen Research Institute of Pharmacy, University of Groningen, Groningen, the Netherlands.
³ Medical Center Leeuwarden, Leeuwarden, the Netherlands.
⁴ Department of Child and Adolescent Psychiatry, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.

Jurjen van der Schans et al. Chest. 2017 Jun.

. 2017 Jun;151(6):1406-1407.

doi: 10.1016/j.chest.2017.03.052.

¹ PharmacoTherapy, -Epidemiology, and -Economics Research Group, Groningen Research Institute of Pharmacy, University of Groningen, Groningen, the Netherlands. Electronic address: j.van.der.schans@rug.nl.
² PharmacoTherapy, -Epidemiology, and -Economics Research Group, Groningen Research Institute of Pharmacy, University of Groningen, Groningen, the Netherlands.
³ Medical Center Leeuwarden, Leeuwarden, the Netherlands.
⁴ Department of Child and Adolescent Psychiatry, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.

No abstract available

Comment in

Attention-Deficit/Hyperactivity Disorder and Comorbid Asthma.
Fluegge K, Fluegge K. Fluegge K, et al. Chest. 2018 May;153(5):1279-1280. doi: 10.1016/j.chest.2018.01.052. Chest. 2018. PMID: 29731041 No abstract available.
Response.
van der Schans J, Hak E, Hoekstra PJ, de Vries TW. van der Schans J, et al. Chest. 2018 May;153(5):1280-1281. doi: 10.1016/j.chest.2018.02.009. Chest. 2018. PMID: 29731042 No abstract available.